Its recognizing biology and making a rational medical decision
The weight follows
References Jastreboff AM, et al
Symptoms could include insomnia, fatigue that feels different, new sensitivity to cold, brain fog, anxiety, and shortness of breath, to name a few
[DOI] [PMC free article] [PubMed] [Google Scholar] 63.Piening A, Ebert E, Gottlieb C, Khojandi N, Kuehm LM, Hoft SG, Pyles KD, McCommis KS, DiPaolo RJ, Ferris ST, Alspach E, Teague RM
CT-388 and CT-868, developed by Carmot Therapeutics, are GIPR/GLP-1R agonists under investigation in obese patients, including those with type 1 diabetes (NCT04838405, NCT06062069)